Log in or Sign up
to access My Account functionalities
Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Diabetic Macular Oedema (DMO)
This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.